Income StatementBalance SheetCash FlowSegments
Gilead Sciences logo

Gilead Sciences Income Statement

Revenue, expenses, and profitability over time

Gilead Sciences generated $29.7B in trailing twelve-month revenue, up 0.0% year-over-year. Net income was $9.2B with a 30.99% net margin. Gross margin stands at 79.35% and operating margin at 34.88%. Diluted EPS is $7.34, which grew 0.5% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$29.7BGross Profit (TTM)$23.6BOperating Income (TTM)$10.4BNet Income (TTM)$9.2BEps Diluted (TTM)$7.34
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$166.82B
P/E Ratio18.10
ROE43.19%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquired IPR&D Expense$0.0$253.0M$61.0M$170.0M$539.0M$107.0M
Stock-Based Compensation Expense$222.0M$209.0M$225.0M$230.0M$230.0M$218.0M
Acquired In-Process Research and Development$0.0$253.0M$61.0M$170.0M$539.0M$107.0M
Share-Based Compensation Expense$222.0M$209.0M$225.0M$230.0M$230.0M$218.0M
Acquired In-Process Research and Development Expenses$0.0$253.0M$61.0M$170.0M$539.0M$107.0M
Adjustment for Amortization$598.0M$599.0M$598.0M$596.0M$597.0M$596.0M
Stock-based compensation expense$222.0M$209.0M$225.0M$230.0M$230.0M$218.0M
Acquired in-process research and development expenses$0.0$253.0M$61.0M$170.0M$539.0M$107.0M
Selling, general and administrative$1.9B$1.3B$1.4B$1.4B$1.8B$1.5B
Share-Based Compensation$222.0M$209.0M$225.0M$230.0M$230.0M$218.0M
Total operating expenses$5.1B$4.4B$4.6B$4.4B$5.9B$4.4B

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Non-Cash Income (Expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M
Other non-cash income (expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M
Interest expense$249.0M$260.0M$254.0M$256.0M$255.0M$240.0M
Change in Accounts Payable—-$105.0M-$162.0M—-$95.0M-$67.0M
Other Non-Cash Income (Expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M
Other income (expense), net—-$328.0M$208.0M$569.0M$349.0M$235.0M
Other Non-cash Income (Expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M
Other Non-Cash Income (Expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital Expenditures$147.0M$104.0M$107.0M$147.0M$205.0M$117.0M
Change in Accounts Receivable-$72.0M-$79.0M$292.0M$333.0M—-$134.0M
Deferred taxes-$379.0M-$199.0M-$178.0M$659.0M—$179.0M
Depreciation$95.0M$97.0M$93.0M$90.0M$90.0M$93.0M
Accounts payable—-$105.0M-$162.0M—-$95.0M-$67.0M
Increase (Decrease) in Accounts Receivable-$72.0M-$79.0M$292.0M$333.0M—-$134.0M
Accrued liabilities$305.0M-$244.0M-$166.0M$811.0M—-$702.0M
Income taxes—-$552.0M-$1.3B-$122.0M-$134.0M-$29.0M
Increase (Decrease) in Inventories$226.0M$223.0M$175.0M$515.0M$123.0M$52.0M
Increase (Decrease) in Prepaid Expense and Other Assets$146.0M-$12.0M-$81.0M$368.0M$36.0M-$5.0M
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation—-$3.4B-$1.6B-$1.5B-$1.3B-$4.2B
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation-$225.0M-$415.0M-$2.1B-$427.0M-$1.8B$1.8B
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$3.0B$1.8B$827.0M$4.1B$3.3B$2.5B
Other Noncash Income (Expense)-$59.0M-$91.0M-$33.0M-$89.0M-$267.0M-$183.0M
Payment for (Proceeds from) Other Investing Activity-$35.0M$23.0M——-$11.0M$17.0M
Payments for Repurchase of Common Stock$350.0M$730.0M$527.0M$435.0M$230.0M$419.0M
Payments of Dividends$973.0M$1.0B$994.0M$1.0B$994.0M$1.0B
Payments to Acquire Debt Securities, Available-for-Sale—$0.0$2.0B$270.0M$1.4B$525.0M
Payments to Acquire Businesses, Net of Cash Acquired$75.0M$273.0M$21.0M$167.0M$609.0M$109.0M
Payments to Acquire Property, Plant, and Equipment$147.0M$104.0M$107.0M$147.0M$205.0M$117.0M
Proceeds from Issuance of Common Stock$173.0M$252.0M$27.0M$97.0M$32.0M$166.0M
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale—$0.0$15.0M$17.0M$23.0M$36.0M
Financing — other-$47.0M-$176.0M-$64.0M-$137.0M-$63.0M-$179.0M
Sale of investments—$0.0$295.0M$219.0M$340.0M$2.5B
Repayments of Debt$7.0M$1.8B$9.0M$9.0M$8.0M$2.8B
Research and development expense$1.6B$1.4B$1.5B$1.3B$1.6B$1.4B
Revenue From Contract With Customer Excluding Assessed Tax$7.6B$6.7B$7.1B$7.8B$7.9B$7.0B
Stock-based compensation$222.0M$209.0M$225.0M$230.0M$230.0M$218.0M

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$1.42$1.06$1.57$2.46$1.76$1.63
Diluted earnings per share$1.42$1.04$1.56$2.43$1.74$1.61
Weighted-average shares, basic—1.2B1.2B1.2B—1.2B
Weighted-average shares, diluted8M1.3B1.3B1.3B—1.3B

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$6.0B$5.1B$5.6B$6.2B$6.3B$5.5B
Operating income$2.5B$2.2B$2.5B$3.3B$2.0B$2.6B

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$2.2B$1.6B$2.4B$3.6B$2.1B$2.6B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$385.0M$334.0M$468.0M$589.0M$0.0$559.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$1.8B$1.3B$2.0B$3.1B$2.2B$2.0B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$1.6B$1.5B$1.5B$1.6B$1.6B$1.4B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$7.6B$6.7B$7.1B$7.8B$7.9B$7.0B